These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

884 related items for PubMed ID: 10636369

  • 1. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen LG, Nicolaes GA, Meijers JC, Bouma BN, Büller HR, Prins MH, Tans G.
    Lancet; 1999 Dec 11; 354(9195):2036-40. PubMed ID: 10636369
    [Abstract] [Full Text] [Related]

  • 2. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G, Curvers J, Middeldorp S, Thomassen MC, Meijers JC, Prins MH, Bouma BN, Büller HR, Rosing J.
    Thromb Haemost; 2000 Jul 11; 84(1):15-21. PubMed ID: 10928463
    [Abstract] [Full Text] [Related]

  • 3. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR.
    Lancet; 1997 Jan 11; 349(9045):83-8. PubMed ID: 8996419
    [Abstract] [Full Text] [Related]

  • 4. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF, Crook D, Devenport M, Wynn V.
    Contraception; 1995 Sep 11; 52(3):143-9. PubMed ID: 7587185
    [Abstract] [Full Text] [Related]

  • 5. Effect of oral contraceptive progestins on serum copper concentration.
    Berg G, Kohlmeier L, Brenner H.
    Eur J Clin Nutr; 1998 Oct 11; 52(10):711-5. PubMed ID: 9805216
    [Abstract] [Full Text] [Related]

  • 6. Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM, Algra A, Meijers JC, Bouma BN, Grobbee DE.
    Blood Coagul Fibrinolysis; 2002 Jul 11; 13(5):373-81. PubMed ID: 12138364
    [Abstract] [Full Text] [Related]

  • 7. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M, Røde A, Westergaard J.
    Br J Obstet Gynaecol; 1993 Sep 11; 100(9):832-8. PubMed ID: 8218004
    [Abstract] [Full Text] [Related]

  • 8. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM, de Souza JC, da Silva AR, de Acosta OM, Alvarez F, Brache V, Garza Flores J, Vasquez-Estrada L, Santo R, Bassol S.
    Clin Pharmacol Ther; 1993 Jan 11; 53(1):65-75. PubMed ID: 8422744
    [Abstract] [Full Text] [Related]

  • 9. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM, Algra A, Meijers JC, Bouma BN, Grobbee DE.
    Thromb Haemost; 2002 Feb 11; 87(2):199-205. PubMed ID: 11859850
    [Abstract] [Full Text] [Related]

  • 10. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR.
    Thromb Haemost; 2000 Jul 11; 84(1):4-8. PubMed ID: 10928461
    [Abstract] [Full Text] [Related]

  • 11. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
    Koetsawang S, Charoenvisal C, Banharnsupawat L, Singhakovin S, Kaewsuk O, Punnahitanont S.
    Contraception; 1995 Apr 11; 51(4):225-9. PubMed ID: 7796587
    [Abstract] [Full Text] [Related]

  • 12. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Büller HR, Vandenbroucke JP.
    Lancet; 1995 Dec 16; 346(8990):1593-6. PubMed ID: 7500751
    [Abstract] [Full Text] [Related]

  • 13. Effects of oral contraceptives on hemostasis and thrombosis.
    Rosing J, Tans G.
    Am J Obstet Gynecol; 1999 Jun 16; 180(6 Pt 2):S375-82. PubMed ID: 10368524
    [Abstract] [Full Text] [Related]

  • 14. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA, Bonnar J.
    Br J Obstet Gynaecol; 1996 Mar 16; 103(3):261-7. PubMed ID: 8630312
    [Abstract] [Full Text] [Related]

  • 15. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C.
    Lancet; 1995 Dec 16; 346(8990):1589-93. PubMed ID: 7500750
    [Abstract] [Full Text] [Related]

  • 16. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN, Liew D, Ratnam SS.
    Contraception; 1989 Jan 16; 39(1):21-35. PubMed ID: 2521321
    [Abstract] [Full Text] [Related]

  • 17. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul 16; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 18. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D, Godsland IF, Worthington M, Felton CV, Proudler AJ, Stevenson JC.
    Am J Obstet Gynecol; 1993 Nov 16; 169(5):1183-9. PubMed ID: 8238183
    [Abstract] [Full Text] [Related]

  • 19. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K.
    Contraception; 1992 Jun 16; 45(6):523-32. PubMed ID: 1535580
    [Abstract] [Full Text] [Related]

  • 20. Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review.
    Winkler UH.
    Am J Obstet Gynecol; 1998 Sep 16; 179(3 Pt 2):S51-61. PubMed ID: 9753311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.